For the quarter ended June 2025, Merit Medical (MMSI) reported revenue of $382.46 million, up 13.2% over the same period last year. EPS came in at $1.01, compared to $0.92 in the year-ago quarter.
The reported revenue represents no surprise over the Zacks Consensus Estimate of $0 million. With the consensus EPS estimate being $0.86, the EPS surprise was +17.44%.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Merit Medical performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Geographic Sales- United States: $227.08 million versus $220.3 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +16.7% change.
- Geographic Sales- International: $155.38 million versus $151.04 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +8.4% change.
- Revenue- Cardiovascular- Peripheral Intervention: $142.85 million versus the six-analyst average estimate of $144.62 million. The reported number represents a year-over-year change of +2.6%.
- Revenue- Cardiovascular- Cardiac Intervention: $115.25 million versus $104.93 million estimated by six analysts on average. Compared to the year-ago quarter, this number represents a +22.8% change.
- Revenue- Endoscopy: $18.44 million versus $18.66 million estimated by six analysts on average. Compared to the year-ago quarter, this number represents a +81% change.
- Revenue- Cardiovascular- OEM: $52.29 million versus $52.65 million estimated by six analysts on average. Compared to the year-ago quarter, this number represents a +18.1% change.
- Revenue- Cardiovascular: $364.03 million versus the six-analyst average estimate of $353.56 million. The reported number represents a year-over-year change of +11.1%.
- Revenue- Cardiovascular- Custom Procedural Solutions: $53.63 million versus the six-analyst average estimate of $51.05 million. The reported number represents a year-over-year change of +6.4%.
View all Key Company Metrics for Merit Medical here>>>
Shares of Merit Medical have returned -11.8% over the past month versus the Zacks S&P 500 composite's +3.4% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Merit Medical Systems, Inc. (MMSI): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
